Suppr超能文献

继发于磷尿性间叶肿瘤的股骨内固定装置失效:1例病例报告及文献复习

Failure of femoral internal fixation device secondary to phosphaturic mesenchymal tumor: a case report and literature review.

作者信息

Zeng Ningjing, Zhang Linzhu, Zhang Lian, Yu Ningzhi, Huang Chuyu, Yang Peng, Lv Yang, Li Xing, Liu Hongliang, Guo Da, Xu Shuchai, Liu Yan

机构信息

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Shenzhen Children's Hospital, Shenzhen, Guangdong, China.

出版信息

BMC Musculoskelet Disord. 2025 Sep 1;26(1):831. doi: 10.1186/s12891-025-09066-0.

Abstract

BACKGROUND

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by mesenchymal tumors that secrete fibroblast growth factor 23 (FGF23). Phosphaturic mesenchymal tumor (PMT) is a novel histopathologic entity that has been identified as a separate cause of TIO. Clinically, PMT is typically diagnosed late due to its rarity.

CASE PRESENTATION

The paper reports on a patient with a sustained left-sided sub-trochanteric femur fracture in 2018 who subsequently underwent fracture reduction and internal fixation placement. Six years postoperatively, the patient developed a recurrent femoral stem fracture accompanied by internal fixation device failure on the left side of the femur with no apparent causative factors. Based on the patient's history of multiple fractures, a series of tests were performed and he was diagnosed with a rare disease recognized as TIO. A PET-CT scan conducted prior to surgery revealed that the lesion was located in the right suprapatellar bursa, so the mass was palpated on the body surface and surgically excised.

CONCLUSIONS

It is the first reported case of TIO in a patient with internal fixation device failure. Following a thorough review of the patient's medical history, examination findings, and associated literature, the study concluded that the patient's long-term osteomalacia and hypophosphatemia would significantly compromise the stability of the internal fixation. Specifically, we determined that the primary tumor lesion in this case was the primary cause of internal fixation failure. Therefore, patients found to have difficult-to-correct hypophosphatemia with multiple fractures in clinical practice should be further investigated for the primary etiology, such as TIO as mentioned in this case, before fracture surgery is performed. Enhancing 68 Ga-DOTA-TATE Positron Emission Tomography/ Computed Tomography (PET/CT) is also recommended to provide a more precise diagnosis of the tumor. For definite tumor lesions, total excisional surgery is considered to be a viable treatment for TIO.

摘要

背景

肿瘤诱导的骨软化症(TIO)是一种由分泌成纤维细胞生长因子23(FGF23)的间充质肿瘤引起的罕见副肿瘤综合征。磷酸尿性间充质肿瘤(PMT)是一种新的组织病理学实体,已被确定为TIO的另一个病因。临床上,由于PMT罕见,通常诊断较晚。

病例报告

本文报道了一名2018年左侧股骨转子下持续骨折的患者,随后接受了骨折复位和内固定置入术。术后六年,患者左侧股骨出现复发性股骨干骨折并伴有内固定装置失效,且无明显病因。基于患者多次骨折的病史,进行了一系列检查,他被诊断为一种罕见疾病,即TIO。术前进行的PET-CT扫描显示病变位于右髌上囊,因此在体表触及肿块并进行了手术切除。

结论

这是首例报道的内固定装置失效患者发生TIO的病例。在全面回顾患者的病史、检查结果及相关文献后,该研究得出结论,患者的长期骨软化症和低磷血症会显著损害内固定的稳定性。具体而言,我们确定该病例中的原发性肿瘤病变是内固定失败的主要原因。因此,在临床实践中,对于发现有难以纠正的低磷血症且伴有多次骨折的患者,在进行骨折手术前应进一步调查原发性病因,如本病例中提到的TIO。还建议加强68 Ga-DOTA-TATE正电子发射断层扫描/计算机断层扫描(PET/CT)以更精确地诊断肿瘤。对于明确的肿瘤病变,完全切除手术被认为是治疗TIO的可行方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验